Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells.

In Brief: Developing novel therapies to cure and manage endometriosis is a major unmet need that will benefit over 180 million women worldwide. Results from the current study suggest that inhibitors of oxidative phosphorylation may serve as novel agents for the treatment of endometriosis.

Abstract: Current therapeutic strategies for endometriosis focus on symptom management and are not curative.